doi: 10.3389/fpsyt.2024.1295766 Received 17 September 2023 Accepted 22 January 2024 Published 09 February 2024 Volume 15 - 2024 Edited by Kiran Veer Sandhu, University College Cork, Ireland Reviewed by Hossein Dabiri, Shahid Beheshti University of Medical Sciences, Iran Sangyong Jung, CHA University, Republic of Korea Padhmanand Sudhakar, Kumaraguru College of Technology, India Updates Copyright 2024 Luqman, He, Hassan, Ullah, Zhang, Rashid Khan, Din, Ullah, Wang and Wang
With structured follow-ups at Set Point Medical Weight Loss Clinic, Watson ensures results are safe, measurable, and long-lasting
[Abstract] ACS Med Chem Lett
150 mg/kg
The combined effect is a gradual, sustained lowering of blood sugar levels
Novo Nordisk - Regulatory Approval (December 2025): FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill-which launched in January 2026 [3]